WXFL10230486

N/A

Report date: 2023/11/21 20:03:29
NME

Base Information

Drug NameWXFL10230486
Drug Alias NameWXFL-10230486WX-486HWH-486
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsChronic UrticariaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuxi Apptec Co LtdHumanwell Healthcare (Group) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHubei Bio-Pharmaceutical Industrial Technological Institute IncHumanwell Healthcare (Group) Co Ltd
Inactive CompaniesN/A
Active IndicationsChronic UrticariaArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A